Here, our studies demonstrate that the metabolic parameters of NASH including glucose tolerance, hepatic triglycerides, and steatosis are not significantly altered with HSC depletion or pharmacologic inhibition of aCDase. This evidence concerns the gene ASAH1 and metabolic dysfunction-associated steatohepatitis.